Related Experiment Video
Updated: Jul 4, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Low leptin levels in migraine: a case control study.
Baburhan Guldiken1, Sibel Guldiken, Muzaffer Demir
1Trakya University-Neurology, Edirne, Turkey.
Headache
|June 13, 2008
Summary
Migraine patients exhibit lower leptin levels and reduced fat mass compared to controls. These findings suggest a potential link between adipocytokine levels and migraine pathogenesis, warranting further investigation.
Area of Science:
- Neurology
- Endocrinology
- Metabolic Syndrome
Background:
- Obesity is a risk factor for episodic migraine transformation to chronic migraine.
- Adipocytokines, such as leptin, may modulate neurogenic inflammation implicated in migraine.
- Interleukin-6 and tumor necrosis factor are cytokines involved in migraine pathogenesis.
Purpose of the Study:
- To assess serum leptin levels in migraine patients during headache-free periods.
- To investigate the relationship between leptin levels and vascular risk factors in migraineurs.
- To compare leptin levels and body composition between episodic migraine patients and controls.
Main Methods:
- Sixty-one episodic migraine patients and 64 controls were enrolled.
- Demographic, anthropometric, glucose, and lipid parameters were collected.
- Serum leptin levels were measured using ELISA in fasting samples.
Main Results:
- Migraine patients showed significantly lower leptin levels than controls (P < .05).
- No significant difference in body mass index was observed between groups.
- Migraineurs had significantly lower fat mass and fat percentage (P < .001).
Conclusions:
- Migraine patients demonstrate reduced leptin levels and fat mass.
- These findings suggest a potential role for low leptin and fat mass in migraine pathogenesis.
- Further studies are needed to explore the clinical implications for migraine prevalence, characteristics, and treatment.
